Senate Democrats Reintroduce Cannabis Descheduling Bill

Bill Would End Federal Cannabis Prohibition

The reintroduced legislation would fully deschedule cannabis from the Controlled Substances Act, ending federal prohibition entirely. This approach differs fundamentally from the Biden administration's ongoing rescheduling effort, which would move cannabis from Schedule I to Schedule III but maintain federal controls.

Sponsors include Senate Majority Leader Chuck Schumer (D-NY), Sen. Cory Booker (D-NJ), and Sen. Ron Wyden (D-OR). The trio first introduced similar legislation in 2022 as the Cannabis Administration and Opportunity Act, which stalled without a floor vote.

Descheduling would eliminate the Controlled Substances Act's criminal penalties for cannabis possession, cultivation, and distribution at the federal level. States would retain full authority to regulate or prohibit cannabis within their borders.

Expungement and Social Equity Provisions

The bill includes automatic expungement of federal cannabis convictions and establishes grant programs for communities harmed by prohibition. Individuals with prior federal marijuana convictions would see those records sealed and cleared without requiring individual petitions.

A Cannabis Justice Office within the Department of Justice would administer community reinvestment grants. Funding would target job training, reentry services, and small business loans in communities with high rates of cannabis arrests.

Think of it this way: the equity provisions mirror state-level social equity frameworks now operating in Illinois, New York, and California, but apply them at the federal level with dedicated appropriations.

Tax and Regulatory Framework

The bill would impose a federal excise tax on cannabis sales, starting at 10% and escalating to 25% over five years. Revenue would fund the community reinvestment programs, substance abuse treatment, and law enforcement training.

The Food and Drug Administration would gain regulatory authority over cannabis products, similar to its oversight of tobacco and alcohol. The Bureau of Alcohol, Tobacco, Firearms and Explosives would enforce federal licensing requirements for interstate cannabis commerce.

Industry groups argue the tax structure would price legal operators out of competition with illicit markets. State-legal cannabis already faces effective federal tax rates exceeding 70% under Internal Revenue Code Section 280E, which disallows business deductions for Schedule I substances.

Political Prospects Remain Uncertain

The bill faces steep obstacles in the current Senate, where Republicans hold 52 seats and have shown limited appetite for comprehensive legalization. No Republican senators have signed on as co-sponsors. Majority Leader Mitch McConnell (R-KY) has historically opposed cannabis reform.

Democrats appear focused on messaging and coalition-building ahead of the 2028 elections rather than immediate passage. Polling consistently shows 70% public support for federal legalization, including majorities of Republican voters.

For full background on federal cannabis policy, see the CannIntel topic hub on federal cannabis descheduling.

Industry and Advocacy Response

Cannabis industry groups welcomed the bill's reintroduction but emphasized the need for bipartisan support to advance. The National Cannabis Industry Association called the legislation "the gold standard for comprehensive reform" while acknowledging the political headwinds.

NORML and the Drug Policy Alliance praised the expungement and equity provisions as essential justice measures. Both organizations have criticized the DEA's pending rescheduling proposal as insufficient because it would leave federal prohibition intact.

The reintroduction comes as the DEA weighs public comments on its proposed rule to move cannabis to Schedule III. That administrative process, initiated by the Biden administration in 2024, represents a separate and more politically feasible path to limited federal reform.